FY10.1 Phase I Awards

The Chemical and Biological Defense (CBD) SBIR Program received 127 Phase I proposals in response to the 10.1 DoD SBIR Solicitation, which closed on 13 January 2010. The 10.1 Solicitation contained 10 topics. The Phase I proposals received a comprehensive technical evaluation in accordance with the evaluation criteria published in the Solicitation, and were prioritized for award. The CBD SBIR award process resulted in the identification of 21 Phase I proposals for negotiation and award. Awards will be made pending successful negotiations and availability of FY10 funds. The procurement office for the service or organization that generated the respective solicitation topic will contact selected companies to begin the negotiation process.

Topic Title Company
CBD10-110 Next Generation Integrated Electrophoretic Nanofluidic Biochip Sensor Platform for the THz Spectroscopic Finger Printing of Biological Species and Agents Redondo Optics, Inc.
CBD10-109 Blood Brain Barrier Drug Delivery of Therapeutics for Chemical Warfare Agents Impel NeuroPharma
CBD10-108 Electrochemical Screening of Multiple Enzymes Relevant to Organophosphate Poisioning Lynntech, Inc.
CBD10-108 A High-Throughput Blood Esterase Panel Assay Agave BioSystems, Inc.
CBD10-107 Microfluidic Dielectrophoretic Screening System Physical Optics Corporation
CBD10-107 Microfluidic High-throughput Platform for Determining of Kinetic Constants of Enzyme Variants CFD Research Corporation
CBD10-106 AC Impedance Sensor for Collective Protection Filter Residual Life Indicator Guild Associates, Inc.
CBD10-106 Miniature Residual Life Indicator Physical Optics Corporation
CBD10-106 Residual Life Indicator for Adsorptive and Reactive Single-Pass Filtration Systems Morphix Technologies, Inc.
CBD10-105 Focal Plane Array Technology for Passive Hyperspectral Standoff Detection EPIR Technologies Inc
CBD10-105 Low noise longwave infrared (8-12µm) focal plane array with high sensitivity for passive hyperspectral standoff detection Applied NanoFemto Technologies LLC
CBD10-104 MEMS Lamellar Based Interferometer for the Detection of Toxic Chemicals EPIR Technologies Inc
CBD10-104 MEMS Lamellar Based Interferometer for the Detection of Toxic Chemicals Agiltron Corporation
CBD10-103 A Novel Microfludic Device for Drug Toxicity Studies CFD Research Corporation
CBD10-103 3D Microfluidic Platform for in vitro Hematopoietic Stem Cell (HSC) Culture Physical Optics Corporation
CBD10-103 In vitro Models Suitable for High-throughput Screening of Drug Toxicities in Human Tissues Nico Technologies Corp.
CBD10-102 Improved Formulations to Enhance Bio-availability for Antisense Therapeutics LNK Chemsolutions, LLC
CBD10-102 Multifunctional Antisense Therapeutics Nanocarrier and Inhalation Device Physical Optics Corporation
CBD10-101 No Power Detection and Identification of Nerve Agents Lynntech, Inc.
CBD10-101 Low/No Power Detector for Organophosphate Nerve Agents Luna Innovations Incorporated
Last Update: March 26, 2014